Form 4: NewAmsterdam Pharma Co N.V. Executive Louise Kooij Reports Share Transactions
SEC Form 4 Filing
Chief Accounting Officer Louise Kooij reports acquisition and disposal of NewAmsterdam Pharma Co N.V. shares.
Summary
- Louise Kooij, Chief Accounting Officer of NewAmsterdam Pharma Co N.V., reported transactions involving the company's ordinary shares.
- On September 27, 2024, Kooij acquired 45,000 ordinary shares through the exercise of an option.
- Also on September 27, 2024, Kooij disposed of 45,000 ordinary shares.
- On October 1, 2024, Kooij sold 45,000 ordinary shares at a price of $15.72 per share.
- Following these transactions, Kooij directly owns 0 ordinary shares.
- Kooij also holds options to purchase 168,073 ordinary shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing share transactions by an officer. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the transactions of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders, as they reflect the actions of a company officer.
- The sale of shares could be perceived negatively if investors interpret it as a lack of confidence in the company's future prospects, although this is a routine filing.
Key Dates
| Date | Description |
|---|---|
| 07/06/2021 | Original option grant date (replaced later) |
| 11/22/2022 | Option granted to replace original option due to business combination |
| 09/27/2024 | Acquisition of 45,000 shares via option exercise and disposal of 45,000 shares |
| 10/01/2024 | Sale of 45,000 ordinary shares at $15.72 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.